-
Figures from the International Underwriting Association’s most recent report shed some light on the movement.
-
Should Howden be successful in sealing the deal, it will be its third piece of major M&A in just over 12 months for a combined sum of approximately £2.5bn.
-
The competition regulator’s investigation looks to be a procedural matter that will allow the Willis Re saga to conclude.
-
The lower-than-expected losses so far from Ida do not stack up against what is thought to be a $30bn+ cat event.
-
The inability to strike a deal sends both buyer and seller back to square one.
-
If PPL and Deloitte cannot execute this time round, serious questions need to be asked around whether London is approaching its vital modernisation work in the right way.
-
The reputation of the insurance industry has taken a battering after sexual misconduct stories and pandemic disputes.
-
This publication has reported extensively on the ups and downs of the PPL saga, as the company seeks to push ahead on the development of its NextGen platform – a major component of the market-wide push on modernisation.
-
The planned disposal of the syndicate underlines the challenges the cohort of Bermudian entries has faced.
-
Recently one of my colleagues argued that it was time for a “bonfire of PMLs”, as the past five years have shown that the industry has seriously underpriced the kind of $10bn-$20bn loss events that have been happening since Harvey, Irma and Maria landed in 2017.
-
Certainty of coverage and the market’s sensitivity around claims aggregation were key discussion points on the first day of the four-day virtual event.
-
There is no such thing as an average loss year, but investors will still be looking for benchmarks.
-
This current hard cycle in cyber is potentially a once-in-a-generation opportunity to engineer the product as fit for purpose.
-
The ability to meet in person will be a major competitive advantage as the world recovers from Covid-19.
-
The business is working with Fenchurch on what is likely to be a secondary offering that sees HPS and MDP re-invest.
